SUBSCribe
logo
twitterlinkedininstagramUser Profile
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Prescription written in sloppy handwriting? This start-up offers an antidote

          Equipping doctors with digital tools, Farmako aims to build India’s first centralised health record system

          Shailaja Mohapatra - January 14, 2021
        • When the sun shines

          Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia

          Shailaja Mohapatra - January 16, 2021
        • Selling prescription drugs can be a pain. Doceree offers an easy way out

          The pharma-marketing start-up has patented tech to reach the right message to the right doctor 

          Debangana Ghosh - November 04, 2020
        • Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

          Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

          V Keshavdev - December 10, 2020
        • “I do not take the market’s view as gospel truth, but I also do not assume it is foolish or stupid”

          ASK Group’s Bharat Shah on why the market is his guidepost when it comes to deciphering tangible price and intangible value

          N Mahalakshmi - October 17, 2020
        • Chronic profit

          Eris Lifesciences promoter Himanshu Shah sells stock worth ₹968 million 

          Shailaja Mohapatra - October 08, 2020
        • Take a chill pill

          Work from home can be stressful. Let PharmEasy make one chore easier for you

          Shailaja Mohapatra - October 06, 2020
        • Why Aarti Industries’ low-cost manufacturing and relationship with MNCs will power its growth

          Customers have begun to prefer long-term contracts because they want supply security, reveals managing director Rajendra Gogri 

          Krishna Gopalan - September 30, 2020
        • Welcome to the Mad Hatters Party a.k.a investors going overboard on 'quality' companies

          The market has been behaving erratically but amid the insanity here are some sane observations 

          N Mahalakshmi - September 30, 2020
        • Building a future-ready, innovative healthcare industry

          India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic care

          Kiran Mazumdar-Shaw - August 28, 2020